Stephanie J. Lee

Active 1972–2025

289
Papers
55,830
Citations
116
h-index
272
i10-index

Citations

Citations per year for Stephanie J. Lee1974: 1 citations1975: 1 citations1976: 5 citations1977: 2 citations1979: 2 citations1981: 1 citations1985: 1 citations1989: 1 citations1991: 1 citations1993: 4 citations1996: 1 citations1997: 1 citations1998: 3 citations1999: 5 citations2000: 7 citations2001: 13 citations2002: 21 citations2003: 61 citations2004: 118 citations2005: 208 citations2006: 337 citations2007: 377 citations2008: 389 citations2009: 361 citations2010: 392 citations2011: 435 citations2012: 432 citations2013: 388 citations2014: 450 citations2015: 462 citations2016: 430 citations2017: 353 citations2018: 275 citations2019: 1,330 citations2020: 1,503 citations2021: 1,483 citations2022: 1,177 citations2023: 785 citations2024: 1,706 citations2025: 698 citations2026: 15 citations1978: no citations, so this year is not shown1980: no citations, so this year is not shown1982–1984: no citations, so these years are not shown1986–1988: no citations, so these years are not shown1990: no citations, so this year is not shown1992: no citations, so this year is not shown1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,556 citing papers, 29.3% of this breakdownGermany: 1,069 citing papers, 6.9% of this breakdownUnited Kingdom: 969 citing papers, 6.2% of this breakdownItaly: 879 citing papers, 5.7% of this breakdownFrance: 824 citing papers, 5.3% of this breakdownChina: 694 citing papers, 4.5% of this breakdownCanada: 596 citing papers, 3.8% of this breakdownSpain: 538 citing papers, 3.5% of this breakdownNetherlands: 509 citing papers, 3.3% of this breakdownJapan: 414 citing papers, 2.7% of this breakdownAustralia: 410 citing papers, 2.6% of this breakdownSwitzerland: 387 citing papers, 2.5% of this breakdown
0%29.3%Other 23.7%

Fields

  • Medicine81.7%
  • Biochemistry, Genetics and Molecular Biology8.4%
  • Immunology and Microbiology4.7%
  • Neuroscience1.1%
  • Health Professions0.8%
  • Economics, Econometrics and Finance0.6%
  • Other2.7%

Topics

  • Hematopoietic Stem Cell Transplantation11.8%
  • Acute Myeloid Leukemia Research6.2%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.5%
  • Acute Lymphoblastic Leukemia research3.3%
  • Immune Cell Function and Interaction3%
  • T-cell and B-cell Immunology2.9%
  • Other68.3%

Coauthors

All papers

Open in search
  1. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2014 cited by 5,394

  2. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2005 cited by 3,530

  3. Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 cited by 499

  4. Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 770

  5. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sanjay Aggarwal, Jonathan Ieyoub, Olivier Schueller, Laurie Green, Zhongming Yang, Heidi Krenz, Madan Jagasia, Bruce R. Blazar, Steven Z. Pavletic - Blood 2021 cited by 327

  6. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2005 cited by 2,991

  7. Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

    Authors: , , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2020 cited by 711

  8. EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

    Authors: , , , , , , , , , , , , , - Bone Marrow Transplantation 2018 cited by 491

  9. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

    Authors: , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2015 cited by 419

  10. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003–2007 Versus 2013–2017 Cohorts

    Authors: , , , , , , , , , , , , , , , - Annals of Internal Medicine 2020 cited by 278

  11. Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 133

  12. Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 98

  13. ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 186

  14. Development of an Unrelated Donor Selection Score Predictive of Survival after HCT: Donor Age Matters Most

    Authors: , , , , , , , , , , , , , , , , , , , - Biology of Blood and Marrow Transplantation 2018 cited by 167

  15. Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Peter Gale, John Koreth, Nelson J. Chao, Mahmoud Aljurf, Brenda Cooper, Mary J. Laughlin, Jack W. Hsu, Peiman Hematti, Leo F. Verdonck, Melhelm M. Solh, Maxim Norkin, Vijay Reddy, Rodrigo Martino, Shahinaz M. Gadalla, Jenna D. Goldberg, Philip L. McCarthy, Josè Antonio Pérez-Simón, Nandita Khera, Ian D. Lewis, Yoshiko Atsuta, Richard F. Olsson, Wael Saber, Edmund K. Waller, Didier Blaise, Joseph A. Pidala, Paul J. Martin, Prakash Satwani, Martin Bornhäuser, Yoshihiro Inamoto, Daniel J. Weisdorf, Mary M. Horowitz, Steven Z. Pavletic - Biology of Blood and Marrow Transplantation 2014 cited by 435

  16. Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

    Authors: , , , , , , , , , , , , - Blood Advances 2021 cited by 140

  17. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

    Authors: , , , , , , , , - Journal of Clinical Oncology 2006 cited by 2,046

  18. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

    Authors: , , , , , , , , , , , , , , , , , - Blood 2007 cited by 1,240

  19. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Authors: , , , , , , , , , , , , , , , - Blood 2011 cited by 681

  20. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hildegard Greinix, Stefanie Sarantopoulos, Gèrard Socié, Bruce R. Blazar, Joseph Pidala, Carrie L. Kitko, Daniel R. Couriel, Corey Cutler, Kirk R. Schultz, Steven Z. Pavletic, Stephanie J. Lee, Sophie Paczesny - Transplantation and Cellular Therapy 2021 cited by 143

  21. Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 905

  22. An Intracerebral Hemorrhage Care Bundle Is Associated with Lower Case Fatality

    Authors: , , , , , , , , , , - Annals of Neurology 2019 cited by 150

  23. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

    Authors: , , , , , , , , , , , , , , , , - PLoS Medicine 2006 cited by 1,415

  24. Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 363